# Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia

> **NCT01533168** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 12 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **GENETIC:** cytogenetic analysis
- **GENETIC:** nucleic acid sequencing
- **OTHER:** diagnostic laboratory biomarker analysis
- **OTHER:** laboratory biomarker analysis
- **OTHER:** medical chart review

## Key facts

- **NCT ID:** NCT01533168
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2016-05
- **Final completion:** —
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2016-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01533168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01533168, "Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01533168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*